Jean Zeghondy - Publications

Switching CDK4/6 inhibitors to overcome toxicity in HR-positive/HER2-negative advanced breast cancer.

Journal: Tumori

Published: July 31, 2026

Targeted axillary dissection in breast cancer: current evidence and ongoing trials.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: October 31, 2025

Genomic landscape of metastatic breast cancers in young adults: a liquid biopsy analysis of women aged 20-40 years.

Journal: Breast (Edinburgh, Scotland)

Published: October 17, 2025

Comprehensive review of pregnancy associated breast cancer: Clinical features, molecular characteristics and novel therapies.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 26, 2025

Assessing the perceived usefulness and impact of a sexual health consultation service for female patients in a comprehensive cancer center.

Journal: Journal of cancer survivorship : research and practice

Published: April 16, 2025

At-home 1-week hydration improves tolerance and treatment intensity of high-dose cisplatin in locally advanced head and neck cancer: a retrospective study.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: February 19, 2025

Predictive factors of FOLFIRINOX chemotherapy toxicity in pancreatic adenocarcinoma patients.

Journal: Future oncology (London, England)

Published: February 10, 2025

Intercontinental Multidisciplinary Oncology Videoconferencing between the South Pacific and the French mainland: Reasons for medical evacuation after more than 2000 cases of cancers discussed

Journal: Bulletin du cancer

Published: December 10, 2024

Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers.

Journal: Nature communications

Published: December 04, 2024

Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast Cancer.

Journal: JAMA network open

Published: April 03, 2024

Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.

Journal: Cancers

Published: March 06, 2024

Telehealth in breast cancer following the coronavirus disease 2019 pandemic.

Journal: Exploration of targeted anti-tumor therapy

Published: February 03, 2023